<DOC>
	<DOCNO>NCT00193128</DOCNO>
	<brief_summary>In phase I/II trial , evaluate novel combination chemotherapy , use concurrently radiation therapy , preoperative therapy locoregional carcinoma esophagus gastroesophageal junction . In brief phase I portion trial , determine whether 2 drug ( docetaxel/oxaliplatin ) 3 drug ( docetaxel/oxaliplatin/capecitabine ) use concurrently radiation therapy . If 3-drug regimen tolerate , phase II portion proceed regimen . If 3-drug combination consider toxic , phase II study proceed docetaxel/oxaliplatin combination radiation therapy .</brief_summary>
	<brief_title>Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine Radiation Resectable Esophagus Cancer</brief_title>
	<detailed_description>Upon determination eligibility , patient receive : Oxaliplatin + Docetaxel + Capecitabine + Radiation therapy If three-drug chemotherapy regimen , radiation therapy , tolerable , regimen take forward phase II portion trial . If three-drug regimen toxic , phase II portion proceed two-drug regimen Oxaliplatin + Docetaxel + Radiation therapy</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>To include study , must meet following criterion : Adenocarcinoma squamous cell carcinoma esophagus G/E junction . Must surgical candidate No previous treatment esophageal cancer Must measurable evaluable disease Able perform activity daily live minimal assistance Adequate bone marrow , liver kidney function Provide write informed consent You participate study follow apply : Tumor location proximal esophagus Metastatic disease locally advance cancer Moderate severe peripheral neuropathy Serious preexist medical illness Significant heart disease Treated invasive cancer within previous 5 year Women pregnant breastfeed Age &lt; 18 year Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Esophagus Cancer</keyword>
</DOC>